Progression of Cutaneous B-Cell Pseudolymphoma to Cutaneous B-Cell Lymphoma
β Scribed by Brittain F. Kulow; Hernani Cualing; Paul Steele; Judi VanHorn; John C. Breneman; Diya F. Mutasim; Debra L. Breneman
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 320 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1203-4754
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Genomic DNA digests of skin biopsies from 20 patients with cutaneous T-cell lymphomas and pseudolymphomas were studied by hybridization, using probes for the constant region of the T-cell receptor beta chain and the joining region of the immunoglobin heavy chain gene. Skin biopsies from all 20 patie
## ABSTRACT We report two cases of cutaneous Bβcell pseudolymphoma (PCBCL) induced by intradermal antigen injections for specific immune therapy (SIT). In both cases, the lesions had first developed on the area of injection; years later, new lesions appeared far from the original site. The histolog
The Epstein-Barr virus (EBV) genome has recently been identified in Hodgkin's disease (HD) and nodal non-Hodgkin's lymphomas (NHL). In order to elucidate the possible aetiopathogenetic role of EBV in benign and malignant lymphoproliferative disorders we investigated skin specimens from 24 patients w
We report two patients with primary cutaneous B-cell lymphoma who were treated with rituximab, a new anti-CD20 monoclonal antibody. The first patient, who had a diffuse large B-cell lymphoma of the lower leg, achieved an 85% improvement. The second patient, who had a primary cutaneous B-cell lymphom